Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 74.30
-0.20 (-0.27%)
Jul 21, 2026, 12:42 PM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 1.06 billion as of July 21, 2026. Its market cap has decreased by -4.61% in one year.
Market Cap
1.06B
Enterprise Value
1.05B
Revenue
82.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.30
ChartMarket Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 1.06B, a decrease of -42.02%. That is a compound annual growth rate of -10.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 1.06B | 3.47% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | 1.83B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.06B |
| DIVA Laboratories | 1.82B |
| Genetics Generation Advancement | 1.06B |
| Kim Forest Enterprise | 812.16M |
| Sofiva Genomics | 747.13M |
| TFBS Bioscience | 716.25M |
| Pharmigene | 451.66M |
| Welgene Biotech | 419.48M |